New Labeling
Health Canada has forced Allergan to put a new warning label on one of its most popular cosmetic products, Botox. The new label will include a warning about distant toxin spread that could have potentially fatal consequences.
However, some physicians believe that the toxin in Botox rarely spreads when injected for the elimination of wrinkles since only very low doses are administered. Distant toxin spread may only result when the product is used for medical purposes, in the treatment of spasticity or serious neurological ailments, as higher amounts are generally needed. It is also believed that off-label uses or physicians who are inexperienced and lack adequate training can increase the risk of distant toxin spread occurring.
For cosmetic purposes, Botox has been approved to treat frown lines, glabellar lines, and crows’ feet.